Cholestyramine
- Product NDC
- 0245-0536
- 11-digit product format
- 002450536
- Labeler code
- 0245
- Product ID
- 0245-0536_46900dd9-d039-40e6-bef8-c2f6ce2981ff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cholestyramine
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Labeler
- Upsher-Smith Laboratories, Inc.
- Application
- ANDA074557
- Marketing category
- ANDA
- Marketing start
- 1996-08-15
- Marketing end
- 2023-09-30
- Substance
- CHOLESTYRAMINE
- Active strength
- 4 g/9g
- Pharmacologic classes
- Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0245-0536-37 | 00245053637 | 378 g in 1 CAN (0245-0536-37) | 378 g | 2012-01-05 | 2021-09-30 | No | No | Current |
| 0245-0536-60 | 00245053660 | 60 POUCH in 1 CARTON (0245-0536-60) > 9 g in 1 POUCH | 60 pouch | 2012-01-05 | 2023-09-30 | No | No | Current |